282 patents currently held
103 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
10 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Of the 103 now held by other companies, 15 name IMEC VZW as their current owner, and 88 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
17
Ending by 2030
Nov 2026
Next term end
233
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2039 · High confidence
Also notable
Ends Jan 2039 · High confidence
Also notable
Ends Jul 2034 · High confidence
Means and Methods for Single Molecule Peptide Sequencing
US 11,573,238
Cited by 20 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2039.
Immune-Cell Targeted Bispecific Chimeric Proteins and Uses Thereof
US 11,246,911
Cited by 16 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2039.
Targeted Modified TNF Family Members
US 10,035,835
Cited by 14 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Formerly held, still cited
Notable
Ends Apr 2028 · High confidence
Cited by 73 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2028.
now held by Vib VZW
Also notable
Ends Mar 2033 · High confidence
Cited by 47 later US patents, top 10% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
now held by Université de Montpellier
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 16 to 23, 2026 · next Nov 16
- 7 fees due Dec 4 to 27, 2026 · next Dec 4
- 9 fees due Jan 2 to 30, 2027 · next Jan 2
- 6 fees due Feb 1 to 28, 2027 · next Feb 1
- 2 fees due Mar 8 to 22, 2027 · next Mar 8
- 9 fees due Apr 3 to 29, 2027 · next Apr 3
- 7 fees due May 5 to 28, 2027 · next May 5
- 1 fee due Jun 30, 2027The maintenance fee for Reactor for a Cracking Furnace (US 10,518,242) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 5 fees due Jul 7 to 30, 2027 · next Jul 7
- 7 fees due Aug 4 to 25, 2027 · next Aug 4
- 7 fees due Sep 3 to 26, 2027 · next Sep 3
- 1 fee due Oct 23, 2027The maintenance fee for Means and Methods for Oral Protein Delivery (US 11,964,002) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
- 3 fees due Nov 3 to 7, 2027 · next Nov 3
Recent changes
- Sep 24Assignment recorded on US 12,560,615: Universiteit Gent to IMEC VZW Recorded Sep 24, 2026, executed Sep 22, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76134, frame 418.
- 11 of the patents on this record were granted since Aug 17, 2026
What they patent
The 5 largest of its 233 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Clayey Barriers | 11 in force | to Mar 2043 |
| Muscle-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof | 4 in force | to Jan 2038 |
| Liver-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof | 4 in force | to Jun 2030 |
| TUNABLE HYBRID IlI-V/ IV LASER SENSOR SYSTEM-ON-A CHIP FOR REAL-TIME MONITORING OF A BLOOD CONSTITUENT CONCENTRATION LEVEL | 3 in force | to Jan 2041 |
| Means and Methods for Single Molecule Peptide Sequencing | 3 in force | to Jan 2039 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,759,167 | Method for Embedding Dies In force · High confidence | In force | High confidence | |
| US 7,910,030 | Process and Apparatus for Continuous Wet Granulation of Powder Material In force · High confidence | In force | High confidence | |
| US 8,470,785 | Method for Treating Ocular Cancer held by Vib VZW and Universiteit Gent In force · Medium confidence | In force | Medium confidence | |
| US 8,123,084 | Rack and Pinion Drive for By-Pass Cartridge held by Vib VZW and Universiteit Gent In force · Medium confidence | In force | Medium confidence | |
| US 9,636,417 | Mucosal Membrane Receptor and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 10,149,914 | Liver-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof held by Vib VZW and Universiteit Gent In force · Medium confidence | In force | Medium confidence | |
| US 11,654,201 | Liver-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 12,409,236 | Liver-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 8,614,192 | Method for Treating Ocular Cancer In force · High confidence | In force | High confidence | |
| US 8,709,764 | Enzymatic Demethylation of Flavonoids In force · High confidence | In force | High confidence |
Also on record, not counted in the 282: 103 patents in force now held by others · 184 patents ended · 164 applications pending · 199 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.